AI in Drug Leverage Turbine's AI-driven virtual experiments to position your pharma clients for accelerated discovery and reduced Phase II failures, highlighting a path to smarter, faster decision making.

Validated Partnerships Pitch collaboration credibility by citing Turbine's validated work with Bayer and AstraZeneca to potential customers, emphasizing proven applicability to real-world drug programs.

Clinical Translation Target biotech and pharma teams focused on translatability by offering Turbine's virtual disease models as a tool to improve predictive accuracy of patient outcomes and trial design.

Scale and Efficiency Promote the ability to run billions of virtual experiments to de-risk programs, design smarter trials, and scale decision-making across multiple projects and pipelines.

Investor and Growth Signals Use the company’s modest revenue with strong funding and notable backers (Accel, MSD Global Health Innovation Fund) as a talking point for growth potential and long-term value to potential customers seeking innovative partners.